Orchidia Pharmaceutical Industries (Orchidia) is an outstanding Egyptian company specialized in the production of pharmaceutical ophthalmic products, ranked number two in the Egyptian ophthalmic market with the highest growth rate in this market. Orchidia has its own manufacturing facility in Al-Obour city on 6,000 M² Footprint and considered one of the biggest in the Middle East region with a current production capacity of 35 million units. Orchidia certified with WHO-GMP implementation from Egyptian MOH and other countries of registration in the Middle East and Africa, ISO 9001, ISO 14001 and OHSAS. We maintain and continually improve our Quality Management Systems (QMS) and Environmental Health and Safety (EHS) to achieve the required quality level and exceeding expectations of our stakeholders. Our current portfolio includes 35 ophthalmic drugs, and 3 medical devices obtain the CE marked certificates. In addition to a rich pipeline of 60 drugs in different ophthalmic drug forms
